Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment …
L Von Seidlein, S Auburn, F Espino, D Shanks… - Malaria journal, 2013 - Springer
The diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency
is a crucial aspect in the current phases of malaria control and elimination, which will require …
is a crucial aspect in the current phases of malaria control and elimination, which will require …
Distribution of G6PD deficiency genotypes among Southeast Asian populations
IS Tantular, F Kawamoto - Tropical Medicine and Health, 2021 - Springer
Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a group of X-linked,
hereditary genetic disorders caused by mutations in the G6PD gene and results in functional …
hereditary genetic disorders caused by mutations in the G6PD gene and results in functional …
G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria
AW Satyagraha, A Sadhewa, V Baramuli… - PLoS neglected …, 2015 - journals.plos.org
Safe treatment of Plasmodium vivax requires diagnosis of both the infection and status of
erythrocytic glucose-6-phosphate dehydrogenase (G6PD) activity because hypnozoitocidal …
erythrocytic glucose-6-phosphate dehydrogenase (G6PD) activity because hypnozoitocidal …
[HTML][HTML] Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter
CS Chu, G Bancone, M Kelley, N Advani… - Wellcome open …, 2020 - ncbi.nlm.nih.gov
Safe access to the most effective treatment options for Plasmodium vivax malaria are limited
by the absence of accurate point-of-care testing to detect glucose-6-phosphate …
by the absence of accurate point-of-care testing to detect glucose-6-phosphate …
Progress towards malaria elimination in Sabang municipality, Aceh, Indonesia
Background Indonesia has set 2030 as its deadline for elimination of malaria transmission in
the archipelago, with regional deadlines established according to present levels of malaria …
the archipelago, with regional deadlines established according to present levels of malaria …
[HTML][HTML] Prevalence of glucose 6-phosphate dehydrogenase variants in malaria-endemic areas of south central timor, eastern Indonesia
N Sulistyaningrum, D Arlinda… - The American Journal …, 2020 - ncbi.nlm.nih.gov
Primaquine is an effective anti-hypnozoite drug for Plasmodium vivax and Plasmodium
ovale. However, it can trigger erythrocyte hemolysis in people with glucose 6-phosphate …
ovale. However, it can trigger erythrocyte hemolysis in people with glucose 6-phosphate …
Further molecular analysis of G6PD deficiency variants in southern Vietnam and a novel variant designated as G6PD Ho Chi Minh (173 A> G; 58 Asp> Gly): frequency …
F Kawamoto, H Matsuoka, NM Phamd… - Acta Medica …, 2017 - ousar.lib.okayama-u.ac.jp
We conducted a survey of glucose-6-phosphate dehydrogenase (G6PD) deficiency among
newborn babies at Tu Du Hospital, Ho Chi Minh, southern Vietnam. A total of 90 deficient …
newborn babies at Tu Du Hospital, Ho Chi Minh, southern Vietnam. A total of 90 deficient …
Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan …
W Zeng, N Liu, Y Li, A Gao, M Yuan, R Ma… - Frontiers in Public …, 2022 - frontiersin.org
Primaquine, the only licensed antimalarial drug for eradication of Plasmodium vivax and
Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6 …
Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6 …
[HTML][HTML] Prevalencia de anemias hemolíticas hereditarias detectadas por tamiz metabólico ampliado en los servicios de salud de Petróleos Mexicanos
LY Hernández-Verdugo… - Revista Mexicana de …, 2023 - medigraphic.com
Introducción: el tamiz metabólico ampliado (TMA) para recién nacidos incluye la detección
de anemias hemolíticas hereditarias (AHH). Objetivo: estimar la prevalencia de AHH en la …
de anemias hemolíticas hereditarias (AHH). Objetivo: estimar la prevalencia de AHH en la …
Prevalence of hereditary hemolytic anemias detected by extended newborn screening in the health services of Petróleos Mexicanos
LY Hernández-Verdugo… - Revista Mexicana de …, 2023 - medigraphic.com
Introduction: extended newborn screening (ENS) includes the detection of hereditary
hemolytic anemias (HHA). Objective: to estimate the prevalence of HHA in the pediatric …
hemolytic anemias (HHA). Objective: to estimate the prevalence of HHA in the pediatric …